Total Payments
$450,127
2024 Payments
$26,184
Companies
33
Transactions
692
Medicare Patients
20,270
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$358,297 (79.6%)
Travel$52,783 (11.7%)
Food & Beverage$20,127 (4.5%)
Consulting$17,805 (4.0%)
Research$1,015 (0.2%)
Education$100.60 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $358,297 | 194 | 79.6% |
| Travel and Lodging | $52,783 | 89 | 11.7% |
| Food and Beverage | $20,127 | 384 | 4.5% |
| Consulting Fee | $17,805 | 9 | 4.0% |
| Unspecified | $1,015 | 7 | 0.2% |
| Education | $100.60 | 9 | 0.0% |
Payments by Type
General
$449,112
685 transactions
Research
$1,015
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $169,663 | 207 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81,960 | 78 | $0 (2024) |
| PFIZER INC. | $49,861 | 53 | $0 (2023) |
| Amarin Pharma Inc. | $39,795 | 60 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $26,612 | 33 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $26,147 | 23 | $0 (2024) |
| Lilly USA, LLC | $22,660 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $10,919 | 24 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $7,700 | 9 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $5,260 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,184 | 67 | Amgen Inc. ($16,046) |
| 2023 | $42,685 | 66 | Amgen Inc. ($27,778) |
| 2022 | $53,073 | 68 | Amgen Inc. ($25,459) |
| 2021 | $56,515 | 70 | Amgen Inc. ($27,047) |
| 2020 | $67,882 | 97 | PFIZER INC. ($19,808) |
| 2019 | $85,075 | 137 | Amarin Pharma Inc. ($26,832) |
| 2018 | $77,722 | 123 | Amgen Inc. ($26,014) |
| 2017 | $40,991 | 64 | Amgen Inc. ($20,878) |
All Payment Transactions
692 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $93.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/23/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/11/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $127.70 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/10/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $94.60 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $89.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $39.61 | General |
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $110.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $126.46 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $107.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $72.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $79.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: Cardiology | ||||||
| 07/02/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Heart Failure and Hypertension | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients With Type 2 Diabetes | SANOFI US SERVICES INC. | $1,015 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 4,860 | 7,108 | $1.0M | $297,974 |
| 2022 | 43 | 5,007 | 7,346 | $1.1M | $315,596 |
| 2021 | 48 | 5,417 | 7,994 | $1.2M | $383,874 |
| 2020 | 47 | 4,986 | 7,270 | $889,916 | $300,821 |
Total Patients
20,270
Total Services
29,718
Medicare Billing
$1.3M
Procedure Codes
209
All Medicare Procedures & Services
209 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 863 | 1,164 | $261,900 | $91,210 | 34.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 648 | 660 | $132,000 | $31,150 | 23.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 255 | 256 | $112,100 | $29,688 | 26.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 247 | $30,875 | $14,856 | 48.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 957 | 1,242 | $74,520 | $10,704 | 14.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 30 | 30 | $30,000 | $9,274 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 86 | 88 | $20,240 | $8,542 | 42.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 30 | 150 | $34,500 | $8,146 | 23.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 121 | 386 | $27,020 | $7,334 | 27.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 172 | 550 | $33,000 | $7,215 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 121 | $18,150 | $7,115 | 39.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 30 | 60 | $11,100 | $6,774 | 61.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $13,475 | $5,844 | 43.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 51 | 52 | $17,330 | $5,578 | 32.2% |
| 93355 | Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | Facility | 2023 | 29 | 29 | $15,950 | $4,768 | 29.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 88 | 88 | $15,400 | $4,520 | 29.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 24 | 96 | $5,760 | $4,347 | 75.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 52 | 166 | $20,750 | $3,853 | 18.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 44 | 46 | $10,580 | $3,610 | 34.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 56 | 96 | $6,240 | $3,607 | 57.8% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 41 | 82 | $12,300 | $2,884 | 23.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 102 | 104 | $6,760 | $2,725 | 40.3% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 30 | 151 | $9,760 | $2,680 | 27.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $6,300 | $2,602 | 41.3% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 27 | 326 | $8,150 | $2,244 | 27.5% |
About Dr. James Fairlamb, M.D
Dr. James Fairlamb, M.D is a Cardiovascular Disease healthcare provider based in Columbia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326029745.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Fairlamb, M.D has received a total of $450,127 in payments from pharmaceutical and medical device companies, with $26,184 received in 2024. These payments were reported across 692 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($358,297).
As a Medicare-enrolled provider, Fairlamb has provided services to 20,270 Medicare beneficiaries, totaling 29,718 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 209 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Columbia, MO
- Active Since 11/11/2005
- Last Updated 07/28/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1326029745
Products in Payments
- Repatha (Biological) $169,424
- JARDIANCE (Drug) $99,183
- VYNDAQEL (Drug) $46,241
- Vascepa (Drug) $39,795
- ENTRESTO (Drug) $26,612
- PRALUENT (Drug) $22,164
- PRALUENT ALIROCUMAB INJECTION (Biological) $11,989
- FARXIGA (Drug) $10,494
- PRADAXA (Drug) $5,394
- NO PRODUCT DISCUSSED (Drug) $3,932
- SAR439954 (Drug) $1,015
- PRALUENT (Biological) $970.00
- EMBLEM (Device) $713.57
- BIOMONITOR (Device) $656.04
- GENERAL THERAPIES (Device) $481.43
- BRILINTA (Drug) $407.39
- XARELTO (Drug) $390.30
- ELIQUIS (Drug) $380.87
- AMVIA EDGE (Device) $356.49
- LifeVest (Device) $307.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbia
Dr. Patrick Mccann, M.d, M.D
Cardiovascular Disease — Payments: $687,373
Cardiovascular Disease $687,373
Taishi Hirai, Md, MD
Cardiovascular Disease — Payments: $164,143
Cardiovascular Disease $164,143
Dr. Sultan Siddique, M.d, M.D
Cardiovascular Disease — Payments: $123,448
Cardiovascular Disease $123,448
Dr. James Ampadu, M.d, M.D
Cardiovascular Disease — Payments: $78,753
Cardiovascular Disease $78,753
Michael Cryer, M.d, M.D
Cardiovascular Disease — Payments: $75,074
Cardiovascular Disease $75,074
Venkateshwar Gottipaty, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $73,338
Cardiovascular Disease $73,338